PharmaBioSource Realty provided real estate services to Shire on the divestment of its 93,000 SF Milford, Massachusetts mammalian cell culture roller bottle drug substance manufacturing site to Rentschler Biopharma.

• Service: Real Estate
• Sector: Biotechnology
• Sub-sector: Mammalian Cell Culture Drug Substance
• Engagement Type: Sell Side

PharmaBioSource Realty provided exclusive life sciences real estate services to divest Shire’s mammalian cell culture roller bottle manufacturing site near Boston, MA.

The site was acquired by the Germany-based biotech CDMO Rentschler to establish its first laboratory and manufacturing presence in the U.S.  The site acquisition also included a supply agreement to manufacture products for Shire. PharmaBioSource’s services included a benchmark valuation, buyer target identification, creation of the confidential information memorandum (CIM), data room development and due diligence support.

Press Release